Olsson B - Search Results

1

Specific copy number alterations associated with docetaxel/carboplatin response in ovarian carcinomas.

Osterberg L, Levan K, Partheen K, Delle U, Olsson B, Sundfeldt K, Horvath G. Osterberg L, et al. Among authors: olsson b. Anticancer Res. 2010 Nov;30(11):4451-8. Anticancer Res. 2010. PMID: 21115892

2

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.

Osterberg L, Levan K, Partheen K, Delle U, Olsson B, Sundfeldt K, Horvath G. Osterberg L, et al. Among authors: olsson b. BMC Cancer. 2009 Oct 18;9:368. doi: 10.1186/1471-2407-9-368. BMC Cancer. 2009. PMID: 19835627 Free PMC article.

3

High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.

Möllerström E, Delle U, Danielsson A, Parris T, Olsson B, Karlsson P, Helou K. Möllerström E, et al. Among authors: olsson b. Cancer Genet Cytogenet. 2010 Apr 15;198(2):79-89. doi: 10.1016/j.cancergencyto.2009.12.012. Cancer Genet Cytogenet. 2010. PMID: 20362222

4

Identification of a gene expression signature for survival prediction in type I endometrial carcinoma.

Levan K, Partheen K, Osterberg L, Olsson B, Delle U, Eklind S, Horvath G. Levan K, et al. Among authors: olsson b. Gene Expr. 2010;14(6):361-70. doi: 10.3727/105221610x12735213181242. Gene Expr. 2010. PMID: 20635577 Free PMC article.

5

Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.

Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K. Karlsson E, et al. Among authors: olsson b. BMC Cancer. 2008 Sep 8;8:254. doi: 10.1186/1471-2407-8-254. BMC Cancer. 2008. PMID: 18778486 Free PMC article.

6

Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer.

Karlsson E, Danielsson A, Delle U, Olsson B, Karlsson P, Helou K. Karlsson E, et al. Among authors: olsson b. Cancer Genet Cytogenet. 2007 Jan 15;172(2):139-46. doi: 10.1016/j.cancergencyto.2006.09.019. Cancer Genet Cytogenet. 2007. PMID: 17213022

7

Nonrandom pattern of chromosome aberrations in 17beta-estradiol-induced rat mammary tumors: indications of distinct pathways for tumor development.

Adamovic T, Roshani L, Chen L, Schaffer BS, Helou K, Levan G, Olsson B, Shull JD. Adamovic T, et al. Among authors: olsson b. Genes Chromosomes Cancer. 2007 May;46(5):459-69. doi: 10.1002/gcc.20428. Genes Chromosomes Cancer. 2007. PMID: 17285573

8

Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate.

Carlsson J, Helenius G, Karlsson MG, Andrén O, Klinga-Levan K, Olsson B. Carlsson J, et al. Among authors: olsson b. BMC Cancer. 2013 Jul 29;13:362. doi: 10.1186/1471-2407-13-362. BMC Cancer. 2013. PMID: 23890084 Free PMC article.

9

miREC: a database of miRNAs involved in the development of endometrial cancer.

Ulfenborg B, Jurcevic S, Lindlöf A, Klinga-Levan K, Olsson B. Ulfenborg B, et al. Among authors: olsson b. BMC Res Notes. 2015 Mar 28;8:104. doi: 10.1186/s13104-015-1052-9. BMC Res Notes. 2015. PMID: 25889518 Free PMC article.

10

Gene expression profiling predicts a three-gene expression signature of endometrial adenocarcinoma in a rat model.

Karlsson S, Olsson B, Klinga-Levan K. Karlsson S, et al. Among authors: olsson b. Cancer Cell Int. 2009 May 8;9:12. doi: 10.1186/1475-2867-9-12. Cancer Cell Int. 2009. PMID: 19426485 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters